Medicare Drug Payment Changes Should Be ‘Physician-Driven’ – Former Official Blum
This article was originally published in The Pink Sheet Daily
Former CMS Deputy Administrator Jonathan Blum urges agency to 'build support, build consensus and then test' Part B reforms.
You may also be interested in...
Either through the courts or a postponement by the Trump administration itself, the Medicare Part B rule seems destined to remain dormant instead of going into effect in January as scheduled.
Remember what happened the last time physician groups opposed federal efforts to curtail Medicare spending on Part B drugs?
Heavily rebated drugs may already be meeting the price goals established by the Senate legislation. As a result, price negotiation for drugs covered under Part B are likely to yield greater savings to the Medicare program than Part D.